Screener
TG Therapeutics TGTX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Other expense (income): | ||||
| Interest expense | 16,572 | 6,716 | 24,238 | 13,473 |
| Loss on extinguishment of debt | — | — | 9,153 | — |
| Other income | (5,132) | (2,793) | (7,519) | (6,396) |
| Total other expense | 11,440 | 3,923 | 25,872 | 7,077 |
| Net income before taxes | $10,234 | $30,920 | $30,597 | $36,388 |
| Income tax expense | (2,453) | (2,733) | (3,039) | (3,141) |
| Net income | $7,781 | $28,187 | $27,558 | $33,247 |
Document
FAQ
- What is TG Therapeutics's other income, net (note 6)?
- TG Therapeutics (TGTX) reported other income, net (note 6) of $5.13M in Q2 2026.
- How has TG Therapeutics's other income, net (note 6) changed year-over-year?
- TG Therapeutics's other income, net (note 6) increased by 83.7% year-over-year, from $2.79M to $5.13M.
- What is the long-term trend for TG Therapeutics's other income, net (note 6)?
- Over 3 years (2021 to 2025), TG Therapeutics's other income, net (note 6) has grown at a 67.2% compound annual growth rate (CAGR), from $2.31M to $10.79M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about TG Therapeutics's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude